Literature DB >> 10030746

Castleman disease of the pararenal retroperitoneum: report of a case.

S Okada1, H Maeta, T Maeba, F Goda, S Mori.   

Abstract

We describe herein the case of a 21-year-old woman in whom Castleman disease of the pararenal retroperitoneum was successfully resected. The patient was referred to our hospital from another hospital for investigation of a retroperitoneal mass in the right middle abdomen. Ultrasonography, computed tomography, and magnetic resonance imaging demonstrated a large retroperitoneal mass with heterogeneous imaging characteristics. An aortogram showed arterial feeding to this mass from a few lumbar arteries. Although a definitive preoperative diagnosis could not be made, surgical excision was performed and histopathological examination confirmed a diagnosis of the hyaline type of Castleman disease. The patient had an uneventful postoperative course and was discharged 14 days after her operation. She now leads an active social life without any signs of sequelae or recurrence 14 months later. To the best of our knowledge, only 2% (6/315) of all reported cases of Castleman disease have been located in the pararenal and retroperitoneal area.

Entities:  

Mesh:

Year:  1999        PMID: 10030746     DOI: 10.1007/BF02482246

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  7 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Bilateral localized Castleman disease of the retroperitoneum.

Authors:  Y Ziv; S Shikiar; M Segal; R Orda
Journal:  Eur J Surg Oncol       Date:  1993-04       Impact factor: 4.424

3.  Castleman disease mimicking an aggressive retroperitoneal neoplasm.

Authors:  W K Johnson; P R Ros; C Powers; C Stoupis; K H Segel
Journal:  Abdom Imaging       Date:  1994 Jul-Aug

4.  Angiomatous lymphoid hamartoma. Report of five cases with a review of the literature.

Authors:  K S Tung; L J McCormack
Journal:  Cancer       Date:  1967-04       Impact factor: 6.860

5.  [Angiofollicular lymphoid hyperplasia (Castleman's disease). First case of meso-sigmoid localisation (author's transl)].

Authors:  P Testas; A Pigne; A Voinnesson; A Vieillefond; J Paillas
Journal:  Chirurgie       Date:  1980

6.  Castleman disease. Unusual retroperitoneal location indistinguishable from malignant tumor in preoperative angiographic appearance.

Authors:  H Takihara; G Yamakawa; Y Baba; M Takahashi; T Ishihara
Journal:  Urology       Date:  1993-02       Impact factor: 2.649

7.  Castleman's tumor with retroperitoneal location: a malignant-appearing benign tumor.

Authors:  G Skolnik; L M Wiklund; B Risberg
Journal:  J Surg Oncol       Date:  1985-02       Impact factor: 3.454

  7 in total
  4 in total

1.  Castleman's disease of the mesorectum: report of a case.

Authors:  Mi Ri Hwang; Hee Jin Chang; Min Ju Kim; Guh Jung Seo; Sang Bum Yoo; Ji Won Park; Hyo Seong Choi; Jae Hwan Oh
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

2.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

3.  A case report of retroperitoneal pararenal Castleman's disease associated with myasthenia gravis.

Authors:  Shuai Wang; Shan-Wen Chen; Song-Liang Cai; Bai-Yan Jin
Journal:  World J Surg Oncol       Date:  2014-11-07       Impact factor: 2.754

4.  Localized pancreatic Castleman disease presenting with extrahepatic dilatation of bile ducts: A case report and review of published cases.

Authors:  Edson Gonçalves Ferreira Junior; Philippos Apolinario Costa; Larissa Melo Freire Golveia Silveira; Rafael Valois Vieira; Hugo Alessi Lima Martins Soares; Bruna Menon Loureiro; Nayane Carolina Pertile Salvioni; Jose Roberto Coelho Ferreira Rocha
Journal:  Int J Surg Case Rep       Date:  2018-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.